D2P vs HealthCCS
AI Verdict
Choose D2P if…
Choose D2P if your primary need is to transform 2D medical images into highly detailed, patient-specific 3D anatomical models for advanced surgical planning and the creation of physical 3D printed models. This tool is ideal for surgeons and specialists requiring precise anatomical visualization and manipulation for complex procedures, including the design of custom implants or guides.
View D2P →Choose HealthCCS if…
Choose HealthCCS if your goal is to enhance diagnostic efficiency and accuracy through AI-powered automated detection of diseases and critical findings across a large volume of medical images. This solution is best suited for radiology departments seeking to improve workflow, prioritize urgent cases, and leverage predictive analytics for earlier intervention and population health management.
View HealthCCS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | D2P | HealthCCS |
|---|---|---|
| Pricing | Unknown | Subscription-based; licensing agreements; historical offering of $1 per scan for its ai1 suite. |
| Deployment | Standalone modular software package. | Cloud / On-premise / Hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
D2PD2P (Tool A) offers a dedicated workstation-based software with a DICOM viewer, advanced segmentation tools (manual and deep learning), 3D model editing, and VR visualization. This provides a highly interactive and specialized user experience for creating and manipulating 3D anatomical models. While HealthCCS (Tool B) focuses on automated AI analysis integrated into existing PACS/EHR systems, D2P's direct manipulation and visualization tools make it more 'usable' for its specific purpose of 3D model creation and surgical planning.
Clinical Value
HealthCCSHealthCCS (Tool B) offers broader clinical value by assisting radiologists in earlier and more accurate disease detection across multiple modalities and conditions, including predictive analytics and triage solutions for urgent findings like brain bleeds and pneumothorax. D2P (Tool A) provides significant clinical value in surgical planning and patient-specific device creation through accurate 3D models, particularly in neurosurgery and orthopedics. However, HealthCCS's wider scope of diagnostic assistance and triage capabilities for various diseases, including identifying previously undetected cardiovascular risk, gives it a broader clinical impact.
Pricing & Value
HealthCCSHealthCCS (Tool B) has a more transparent pricing model, historically offering a subscription-based model with a notable $1 per scan for its AI1 suite, which provides a clear and potentially cost-effective value proposition. D2P (Tool A) requires direct contact for pricing, making it difficult to assess its value proposition without engaging sales. The transparency and historical flat-fee model of HealthCCS suggest a stronger value proposition.
Enterprise Readiness
HealthCCSHealthCCS (Tool B) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with flexible deployment options (Cloud/On-premise/Hybrid) and integration with PACS/EHR systems. These features are crucial for seamless enterprise adoption and compliance. While D2P (Tool A) handles PHI in a regulated context and is FDA-cleared, it lacks explicit statements on HIPAA/BAA and its workstation-based deployment might be less flexible for large-scale enterprise integration compared to HealthCCS.
Innovation
HealthCCSBoth tools leverage AI/deep learning. D2P (Tool A) innovates with its integration of Virtual Reality (VR) for advanced visualization in 3D model creation and surgical planning. HealthCCS (Tool B) demonstrates innovation through its broad application of AI for multi-modality disease detection, predictive analytics for patient outcomes, and triage solutions, pushing the boundaries of AI in diagnostic assistance across a wider range of clinical problems, including the development of new CPT codes for its solutions.
Support & Docs
TieNeither the provided structured facts nor web searches offer specific comparative details on the quality or extent of support and documentation for either tool. Both 3D Systems (for D2P) and Nanox.AI (for HealthCCS, formerly Zebra Medical Vision) are established companies in the medical technology space and are expected to provide professional support and documentation for their FDA-cleared medical devices. Without distinguishing information, it is not possible to pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | D2P | HealthCCS |
|---|---|---|
| Product Name | D2P | HealthCCS |
| Company | 3D Systems | Zebra Medical Vision (now Nanox.AI) |
| Primary Use Case | Converts 2D medical imaging data (DICOM) into accurate 3D digital anatomical models for advanced visualization, surgical planning, and 3D printing. | AI-powered medical imaging solutions to assist radiologists in detecting diseases earlier and with greater accuracy. |
| Key AI/Automation Features | Automatic and manual segmentation tools (deep learning driven), Virtual Reality (VR) visualization for non-diagnostic use, 3D model editing tools. | AI-powered disease detection (e.g., cancer, cardiovascular, liver, bone, brain bleeds), predictive analytics, triage solutions for urgent findings, automated detection of critical findings with priority flagging. |
| Supported Imaging Modalities | CT, MR, CBCT | X-ray, CT, MRI, Mammography |
Videos
Demos, reviews, and walkthroughs featuring D2P and HealthCCS.